In follicular NHL patients, the idiotype antigen protein expressed on the tumor cell???s surface is not functioning as an antigen because of its failure to elicit a sufficient immune response to the presence of the tumor cells, and the goal of our BiovaxID active immunotherapy is to trigger the body???s immune system to recognize such protein as an antigen by introducing a purified version of the